M. Crump

660 total citations
20 papers, 462 citations indexed

About

M. Crump is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, M. Crump has authored 20 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in M. Crump's work include Lymphoma Diagnosis and Treatment (7 papers), Colorectal Cancer Treatments and Studies (3 papers) and Breast Cancer Treatment Studies (3 papers). M. Crump is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Colorectal Cancer Treatments and Studies (3 papers) and Breast Cancer Treatment Studies (3 papers). M. Crump collaborates with scholars based in Canada, United States and Italy. M. Crump's co-authors include Frances A. Shepherd, Richard Tsang, David Hodgson, A. Sun, Woodrow Wells, Jayant Sastri Goda, Mary Gospodarowicz, Melania Pintilie, Joseph Beyene and Lillian Sung and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

M. Crump

19 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Crump Canada	9	187	177	121	121	82	20	462
Antonio Scapinello Italy	11	198 1.1×	109 0.6×	218 1.8×	116 1.0×	80 1.0×	42	502
Caroline Kuhlman United States	8	338 1.8×	301 1.7×	65 0.5×	56 0.5×	48 0.6×	12	596
Federico Sackmann Muriel Argentina	12	136 0.7×	144 0.8×	72 0.6×	135 1.1×	55 0.7×	21	438
Luciano Guardigni Italy	7	457 2.4×	361 2.0×	152 1.3×	68 0.6×	79 1.0×	11	560
Omar Hustu United States	8	45 0.2×	107 0.6×	51 0.4×	128 1.1×	81 1.0×	14	392
M. Hoffmann Austria	12	518 2.8×	214 1.2×	112 0.9×	159 1.3×	119 1.5×	20	674
Marin Nola Croatia	11	129 0.7×	120 0.7×	89 0.7×	40 0.3×	66 0.8×	31	405
Leanne Berkahn New Zealand	12	255 1.4×	150 0.8×	124 1.0×	72 0.6×	27 0.3×	36	474
Zsófia Miltényi Hungary	10	146 0.8×	118 0.7×	48 0.4×	52 0.4×	24 0.3×	50	292
D E Austin United Kingdom	9	201 1.1×	109 0.6×	68 0.6×	99 0.8×	105 1.3×	12	405

Countries citing papers authored by M. Crump

Since Specialization

Citations

This map shows the geographic impact of M. Crump's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Crump with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Crump more than expected).

Fields of papers citing papers by M. Crump

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Crump. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Crump. The network helps show where M. Crump may publish in the future.

Co-authorship network of co-authors of M. Crump

This figure shows the co-authorship network connecting the top 25 collaborators of M. Crump. A scholar is included among the top collaborators of M. Crump based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Crump. M. Crump is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuruvilla, John, M. Crump, Diego Villa, et al.. (2017). CANADIAN CANCER TRIALS GROUP (CCTG) LY.17: A RANDOMIZED PHASE II STUDY EVALUATING NOVEL SALVAGE THERAPY PRE‐AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR‐DLBCL) ‐ OUTCOME OF IBRUTINIB + R‐GDP. Hematological Oncology. 35(S2). 88–88. 5 indexed citations

Crump, M., Adriana Scheliga, Jiří Mayer, et al.. (2011). Efficacy and safety of bortezomib-rituximab (VCR) vs rituximab® in patients (PTS) with relapsed, R-naive/-sensitive follicular lymphoma (FL): outcome according to prior therapy. Annals of Oncology. 22. 186–186. 1 indexed citations

Villa, Diego, Tara Seshadri, Noemí Puig, et al.. (2011). Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy. Haematologica. 97(5). 751–757. 15 indexed citations

Tsang, Richard, Melania Pintilie, Julia Skliarenko, et al.. (2011). 9219 POSTER Combined Modality Therapy for Stage l-ll Diffuse Large B-cell Lymphoma Provides Excellent Local Control and Clinical Outcome in the Rituximab Era. European Journal of Cancer. 47. S644–S645. 1 indexed citations

Goda, Jayant Sastri, Mary Gospodarowicz, Melania Pintilie, et al.. (2010). Long‐term outcome in localized extranodal mucosa‐associated lymphoid tissue lymphomas treated with radiotherapy. Cancer. 116(16). 3815–3824. 149 indexed citations

Crump, M., Bertrand Coiffier, Eric D. Jacobsen, et al.. (2007). 6003 ORAL Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in relapsed diffuse large B-cell lymphoma (DLBCL). European Journal of Cancer Supplements. 5(4). 346–346.

Nathan, Paul C., Lillian Sung, M. Crump, & Joseph Beyene. (2004). Consolidation Therapy With Autologous Bone Marrow Transplantation in Adults With Acute Myeloid Leukemia: A Meta-analysis. JNCI Journal of the National Cancer Institute. 96(1). 38–45. 56 indexed citations

Hodgson, David, Robert G. MacKenzie, Natalie J. Forde, et al.. (2004). Cardiac toxicity following modern treatment for hodgkins disease: Impact of combined modality treatment with doxorubicin and mediastinal radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 60(1). S216–S217. 1 indexed citations

Petersen, René Horsleben, Richard Tsang, Melania Pintilie, et al.. (2004). Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone. Journal of Clinical Oncology. 22(14_suppl). 6521–6521. 22 indexed citations

10.

Marks, Lawrence B., Constance Cirrincione, B. Peterson, et al.. (2004). The impact of local/regional radiotherapy (RT), and its timing, on survival following lumpectomy/mastectomy and systemic chemotherapy in patients with ≥10 positive axillary nodes: Analysis of CALGB 9082. International Journal of Radiation Oncology*Biology*Physics. 60(1). S136–S136. 2 indexed citations

11.

Buckstein, Rena, M. Crump, Yuval Shaked, et al.. (2004). Palliation of relapsed aggressive histology NHL with high-dose celecoxib and 'metronomic' low-dose cyclophosphamide. Journal of Clinical Oncology. 22(14_suppl). 3016–3016. 2 indexed citations

12.

Marks, Lawrence B., Constance Cirrincione, Fred Rosner, et al.. (2004). The impact of local/regional radiotherapy (RT), and its timing, on survival following lumpectomy/mastectomy and systemic chemotherapy in patients with ≥10 positive axillary nodes: Analysis of CALGB 9082. International Journal of Radiation Oncology*Biology*Physics. 60. S136–S136. 1 indexed citations

13.

Abraham, R., et al.. (2001). Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplantation. 27(2). 177–182. 29 indexed citations

14.

Marks, L.B., Arvin S. Glicksman, Guy Rosner, et al.. (1999). 94 Preliminary analysis of radiotherapy data from CALGB 9082: variability of treatment fields for local/regional breast cancer and the impact of high dose chemotherapy on the ability to deliver radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 45(3). 195–196. 2 indexed citations

15.

Crump, M., Peter Rubin, Maureen Ross, et al.. (1997). A phase I trial of recombinant human interleukin-1β(OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplantation. 19(4). 315–322. 13 indexed citations

16.

Shepherd, Frances A., et al.. (1996). Final results of the Canadian phase I dose escalation trial of gemcitabine and cisplatin for advanced non-small cell lung cancer.. PubMed. 23(5 Suppl 10). 48–54. 8 indexed citations

17.

Liu, Geoffrey, M. Crump, Paul E. Goss, Janet Dancey, & Frances A. Shepherd. (1996). Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade.. Journal of Clinical Oncology. 14(12). 3141–3147. 52 indexed citations

18.

Shepherd, Frances A., et al.. (1996). Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: usefulness of mathematic modeling to determine maximum-tolerable dose.. Journal of Clinical Oncology. 14(5). 1656–1662. 25 indexed citations

19.

Winquist, Eric, et al.. (1995). Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production.. Journal of Clinical Oncology. 13(1). 157–164. 72 indexed citations

20.

Garrington, George E. & M. Crump. (1968). Pulp death in a patient with lepromatous leprosy. Oral Surgery Oral Medicine Oral Pathology. 25(3). 427–434. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact